Area of research
Orthopedics and Sports Medicine · Oncology
Research interest
Research interests include Bone health and osteoporosis research, Bone health and treatments, Bone Metabolism and Diseases, and Vitamin D Research Studies.
Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX
Body mass index and subsequent fracture risk: a meta-analysis to update FRAX
Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement
Asia–Pacific consensus for the management of osteoporosis in men
A consensus statement on the management of vertebral fractures in CKD stages G4–G5D
A meta-analysis of previous falls and subsequent fracture risk in cohort studies
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX
A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography
Biochemical Markers of Bone Fragility in Patients With Diabetes
Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices
Bone fragility in diabetes: novel concepts and clinical implications
The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
Vitamin K and Osteoporosis
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF
Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk
<i>T</i>-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed
T-score as an Indicator of Fracture Risk on Therapy: Evidence From Romosozumab vs Alendronate Treatment in the ARCH Trial
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study
Diagnosis and management of bone fragility in diabetes: an emerging challenge
Phosphate wasting disorders in adults